Joseph Rudinger memorial lecture: Discovery and applications of cyclotides

Journal of Peptide Science

Volumn 19, Issue 7, 2013, Pages 393-407

  Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cyclic peptides; Cyclotides; Drug design; Structure

Indexed keywords

ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CIRCULIN; CYCLOPSYCHOTRIDE A; CYCLOTIDE; CYCLOVIOLACIN H3; CYCLOVIOLACIN O1; CYCLOVIOLACIN O13; CYCLOVIOLACIN O14; CYCLOVIOLACIN O15; CYCLOVIOLACIN O16; CYCLOVIOLACIN O2; CYCLOVIOLACIN O24; CYCLOVIOLACIN O3; CYCLOVIOLACIN O8; CYCLOVIOLACIN Y4; CYCLOVIOLACIN Y5; HEDYOTIDE B1; HEDYOTIDE B2; KALATA B1; KALATA B2; KALATA B6; KALATA B7; PALICOUREIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VABY A; VABY B;

AMINO ACID SEQUENCE; ANTHELMINTIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; DRUG INDUSTRY; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; HOST RESISTANCE; INSECTICIDAL ACTIVITY; NONHUMAN; OLDENLANDIA; PLANT; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN DETERMINATION; PROTEIN ENGINEERING; PROTEIN ISOLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; RUBIACEAE; VIOLACEAE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; CYCLOTIDES; DRUG DESIGN; MODELS, MOLECULAR; PLANTS; PROTEIN CONFORMATION; PROTEIN ENGINEERING;

EID: 84879023057     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2523     Document Type: Review

References (140)

1. Jones J. The life and work of Josef Rudinger. J. Pept. Sci. 2004; 10: 393-413.
2. Craik DJ. Seamless proteins tie up their loose ends. Science 2006; 311: 1563-1564.
3. Craik DJ, Cemazar M, Daly NL. The chemistry and biology of cyclotides. Curr. Opin. Drug Discov. Devel. 2007; 10: 176-184.
4. Craik DJ, Swedberg JE, Mylne JS, Cemazar M. Cyclotides as a basis for drug design. Expert. Opin. Drug. Discov. 2012; 7: 179-194.
5. Craik DJ, Henriques ST, Mylne JS, Wang CAK. Cyclotide isolation and characterization. Methods Enzymol. 2012; 516: 37-62.
6. Craik DJ. Host-defense activities of cyclotides. Toxins 2012; 4: 139-156.
7. Henriques ST, Craik DJ. Importance of the cell membrane on the mechanism of action of cyclotides. ACS Chem. Biol. 2012; 7: 626-636.
8. Craik DJ, Conibear AC. The chemistry of cyclotides. J. Org. Chem. 2011; 76: 4805-4817.
9. Henriques ST, Craik DJ. Cyclotides as templates in drug design. Drug Discov. Today 2010; 15: 57-64.
10. Daly NL, Craik DJ. Design and therapeutic applications of cyclotides. Future Med. Chem. 2009; 1: 1613-1622.
11. Conlan BF, Colgrave ML, Gillon AD, Guarino R, Craik DJ, Anderson MA. Insights into processing and cyclization events associated with biosynthesis of the cyclic peptide kalata B1. J. Biol. Chem. 2012; 287: 28037-28046.
12. Aboye TL, Camarero JA. Biological synthesis of circular polypeptides. J. Biol. Chem. 2012; 287: 27026-27032.
13. Jagadish K, Camarero JA. Cyclotides, a promising molecular scaffold for peptide-based therapeutics. Biopolymers: Pept. Sci. 2010; 94: 611-616.
14. Goransson U, Burman R, Gunasekera S, Stromstedt AA, Rosengren KJ. Circular proteins from plants and fungi. J. Biol. Chem. 2012; 287: 27001-27006.
15. Pelegrini PB, Quirino BF, Franco OL. Plant cyclotides: an unusual class of defense compounds. Peptides 2007; 28: 1475-1481.
16. Kolmar H. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins. FEBS J. 2008; 275: 2684-2690.
17. Pinto MFS, Fensterseifer ICM, Franco OL. Plant cyclotides: an unusual protein family with multiple functions. Plant Defence: Biol. Cont. 2012; 12: 333-344.
18. Gerlach SL, Mondal D. The bountiful biological activities of cyclotides. Chron. Young Sci. 2012; 3: 169-177.
19. Gruber CW. Global cyclotide adventure: a journey dedicated to the discovery of circular peptides from flowering plants. Biopolymers: Pept. Sci. 2010; 94: 565-572.
20. Garcia AE, Camarero JA. Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr. Mol. Pharmacol. 2010; 3: 153-163.
21. Craik DJ, Daly NL, Bond T, Waine C. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 1999; 294: 1327-1336.
22. Gruber CW, Elliott AG, Ireland DC, Delprete PG, Dessein S, Göransson U, Trabi M, Wang CK, Kinghorn AB, Robbrecht EF, Craik DJ. Distribution and evolution of circular miniproteins in flowering plants. Plant Cell 2008; 20: 2471-2483.
23. Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry 1995; 34: 4147-4158.
24. Colgrave ML, Craik DJ. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 2004; 43: 5965-5975.
25. Kaas Q, Craik DJ. Analysis and classification of circular proteins in CyBase. Biopolymers: Pept. Sci. 2010; 94: 584-591.
26. Gran L. An oxytocic principle found in Oldenlandia affinis DC. Medd. Nor. Farm. Selsk. 1970; 12: 173-180.
27. Gran L. Oxytocic principles of Oldenlandia affinis. Lloydia 1973; 36: 174-178.
28. Sletten K, Gran L. Some molecular properties of kalatapeptide B-1 A uterotonic polypeptide isolated from Oldenlandia affinis DC. Medd. Nor. Farm. Selsk. 1973; 7-8: 69-82.
29. McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell 1993; 73: 421-424.
30. Gustafson KR, Sowder RCI, Henderson LE, Parsons IC, Kashman Y, Cardellina JHI, et al. Circulins A and B: novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. J. Am. Chem. Soc. 1994; 116: 9337-9338.
31. Witherup KM, Bogusky MJ, Anderson PS, Ramjit H, Ransom RW, Wood T, et al. Cyclopsychotride A, A biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J. Nat. Prod. 1994; 57: 1619-1625.
32. Schöpke T, Hasan Agha MI, Kraft R, Otto A, Hiller K. Hämolytisch aktive komponenten aus Viola tricolor L. und Viola arvensis Murray. Sci. Pharm. 1993; 61: 145-153.
33. Claeson P, Göransson U, Johansson S, Luijendijk T, Bohlin L. Fractionation protocol for the isolation of polypeptides from plant biomass. J. Nat. Prod. 1998; 61: 77-81.
34. Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P. Seven novel macrocyclic polypeptides from Viola arvensis. J. Nat. Prod. 1999; 62: 283-286.
35. Wang CK, Hu SH, Martin JL, Sjogren T, Hajdu J, Bohlin L, et al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold. J. Biol. Chem. 2009; 284: 10672-10683.
36. Hernandez JF, Gagnon J, Chiche L, Nguyen TM, Andrieu JP, Heitz A, et al. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 2000; 39: 5722-5730.
37. Mylne JS, Chan LY, Chanson AH, Daly NL, Schaefer H, Bailey TL, et al. Cyclic peptides arising by evolutionary parallelism via asparaginyl-endopeptidase-mediated biosynthesis. Plant Cell 2012; 24: 2765-2778.
38. Poth AG, Mylne JS, Grassl J, Lyons RE, Millar AH, Colgrave ML, et al. Cyclotides associate with leaf vasculature and are the products of a novel precursor in petunia (solanaceae). J. Biol. Chem. 2012; 287: 27033-27046.
39. Poth AG, Colgrave ML, Philip R, Kerenga B, Daly NL, Anderson MA, et al. Discovery of cyclotides in the Fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins. ACS Chem. Biol. 2011; 6: 345-355.
40. Nguyen GKT, Zhang S, Ngan TKN, Phuong QTN, Chiu MS, Hardjojo A, et al. Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family. J. Biol. Chem. 2011; 286: 24275-24287.
41. Ireland DC, Clark RJ, Daly NL, Craik DJ. Isolation, sequencing, and structure-activity relationships of cyclotides. J. Nat. Prod. 2010; 73: 1610-1622.
42. Wang CK, Kaas Q, Chiche L, Craik DJ. CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res. 2008; 36: D206-210.
43. Mulvenna JP, Wang C, Craik DJ. CyBase: a database of cyclic protein sequence and structure. Nucleic Acids Res. 2006; 34: D192-D194.
44. Daly NL, Rosengren KJ, Troeira Henriques S, Craik DJ. NMR and protein structure in drug design: application to cyclotides and conotoxins. Eur. Biophys. J. 2011; 40: 359-370.
45. Wang CK, Colgrave ML, Ireland DC, Kaas Q, Craik DJ. Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes. Biophys. J. 2009; 97: 1471-1481.
46. Craik DJ, Cemazar M, Wang CK, Daly NL. The cyclotide family of circular miniproteins: nature's combinatorial peptide template. Biopolymers: Pept. Sci. 2006; 84: 250-266.
47. Gustafson KR, McKee TC, Bokesch HR. Anti-HIV cyclotides. Curr. Protein Pept. Sci. 2004; 5: 331-340.
48. Burman R, Svedlund E, Felth J, Hassan S, Herrmann A, Clark RJ, et al. Evaluation of toxicity and anti-tumour activity of cycloviolacin O2 in mice. Biopolymers: Pept. Sci. 2010; 94: 626-634.
49. Grundemann C, Koehbach J, Huber R, Gruber CW. Do plant cyclotides have potential as immunosuppressant peptides? J. Nat. Prod. 2012; 75: 167-174.
50. Barry DG, Daly NL, Bokesch HR, Gustafson KR, Craik DJ. Solution structure of the cyclotide palicourein: implications for the development of a pharmaceutical framework. Structure 2004; 12: 85-94.
51. Clark RJ, Daly NL, Craik DJ. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem. J. 2006; 394: 85-93.
52. Craik DJ, Mylne JS, Daly NL. Cyclotides: macrocyclic peptides with applications in drug design and agriculture. Cell. Mol. Life Sci. 2010; 67: 9-16.
53. Aboye TL, Ha H, Majumder S, Christ F, Debyser Z, Shekhtman A, et al. Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J. Med. Chem. 2012; 55: 10729-10734.
54. Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EW. Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J. Med. Chem. 2009; 52: 6197-6200.
55. Thongyoo P, Jaulent AM, Tate EW, Leatherbarrow RJ. Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins. Chembiochem 2007; 8: 1107-1109.
56. Thongyoo P, Roque-Rosell N, Leatherbarrow RJ, Tate EW. Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org. Biomol. Chem. 2008; 6: 1462-1470.
57. Sommerhoff CP, Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Diederichsen U, Kolmar H. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta. J. Mol. Biol. 2010; 395: 167-175.
58. Camarero JA, Kimura RH, Woo YH, Cantor J, Steenblock E. A cell based approach for the biosynthesis/screening of cyclic peptide libraries against bacterial toxins. Chim. Oggi 2007; 25: 20-23.
59. Gunasekera S, Foley FM, Clark RJ, Sando L, Fabri LJ, Craik DJ, et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J. Med. Chem. 2008; 51: 7697-7704.
60. Wong CTT, Rowlands DK, Wong CH, Lo TWC, Nguyen GKT, Li HY, et al. Orally active peptidic bradykinin B-1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew. Chem. Int. Ed. 2012; 51: 5620-5624.
61. Getz JA, Cheneval O, Craik DJ, Daugherty PS. Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration. ACS Chem. Biol. 2013. In press, DOI: 1021/cb4000585
62. Eliasen R, Daly NL, Wulff BS, Andresen TL, Conde-Frieboes KW, Craik DJ. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1. J. Biol. Chem. 2012; 287: 40493-40501.
63. Felizmenio-Quimio ME, Daly NL, Craik DJ. Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. J. Biol. Chem. 2001; 276: 22875-22882.
64. Daly NL, Love S, Alewood PF, Craik DJ. Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Biochemistry 1999; 38: 10606-10614.
65. Tam JP, Lu Y-A. Synthesis of large cyclic cystine-knot peptide by orthogonal coupling strategy using unprotected peptide precursors. Tetrahedron Lett. 1997; 38: 5599-5602.
66. Tam JP, Lu Y-A. A biomimetic strategy in the synthesis and fragmentation of cyclic protein. Protein Sci. 1998; 7: 1583-1592.
67. Tam JP, Lu Y-A, Yu Q. Thia zip reaction for synthesis of large cyclic peptides: mechanisms and applications. J. Am. Chem. Soc. 1999; 121: 4316-4324.
68. Thongyoo P, Tate EW, Leatherbarrow RJ. Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II. Chem. Commun. (Camb.) 2006; 2848-2850.
69. Avrutina O, Schmoldt HU, Gabrijelcic-Geiger D, Wentzel A, Frauendorf H, Sommerhoff CP, et al. Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis. Chembiochem 2008; 9: 33-37.
70. Cemazar M, Craik DJ. Microwave-assisted Boc-solid phase peptide synthesis of cyclic cysteine-rich peptides. J. Pept. Sci. 2008; 14: 683-689.
71. Zheng JS, Chang HN, Shi J, Liu L. Chemical synthesis of a cyclotide via intramolecular cyclization of peptide O-esters. Sci. China. Chem. 2012; 55: 64-69.
72. Zheng JS, Tang S, Guo Y, Chang HN, Liu L. Synthesis of cyclic peptides and cyclic proteins via ligation of peptide hydrazides. Chembiochem 2012; 13: 542-546.
73. Austin J, Wang W, Puttamadappa S, Shekhtman A, Camarero JA. Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem 2009; 10: 2663-2670.
74. Camarero JA, Kimura RH, Woo Y-H, Shekhtman A, Cantor J. Biosynthesis of a fully functional cyclotide inside living bacterial cells. Chembiochem 2007; 8: 1363-1366.
75. Camarero JA, Tran AT, Kwon Y. Biosynthesis of the cyclotide kalata B1 using protein splicing. Protein Sci. 2004; 13: 139-139.
76. Kimura RH, Tran A-T, Camarero JA. Biosynthesis of the cyclotide kalata B1 by using protein splicing. Angew. Chem. Int. Ed. 2006; 118: 987-990.
77. Gunasekera S, Daly NL, Anderson MA, Craik DJ. Chemical synthesis and biosynthesis of the cyclotide family of circular proteins. IUBMB Life 2006; 58: 515-524.
78. Dörnenburg H. Cyclotide synthesis and supply: from plant to bioprocess. Biopolymers: Pept. Sci. 2010; 94: 602-610.
79. Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, et al. Identification and characterization of a new family of cell-penetrating peptides cyclic cell-penetrating peptides. J. Biol. Chem. 2011; 286: 36932-36943.
80. Contreras J, Elnagar AYO, Hamm-Alvarez SF, Camarero JA. Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. J. Control. Release 2011; 155: 134-143.
81. Simonsen SM, Sando L, Rosengren KJ, Wang CK, Colgrave ML, Daly NL, et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J. Biol. Chem. 2008; 283: 9805-9813.
82. Huang YH, Colgrave ML, Clark RJ, Kotze AC, Craik DJ. Lysine-scanning mutagenesis reveals a previously unidentified amendable face of the cyclotide kalata B1 for the optimisation of nematocidal activity. J. Biol. Chem. 2010; 285: 10797-10805.
83. Jagadish K, Borra R, Lacey V, Majumder S, Shekhtman A, Wang L, et al. Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions. Angew. Chem. Int. Ed. 2013; 52: 3126.
84. Jennings C, West J, Waine C, Craik D, Anderson M. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 10614-10619.
85. Jennings CV, Rosengren KJ, Daly NL, Plan M, Stevens J, Scanlon MJ, et al. Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Mobius strips exist in nature? Biochemistry 2005; 44: 851-860.
86. Göransson U, Sjogren M, Svangard E, Claeson P, Bohlin L. Reversible antifouling effect of the cyclotide cycloviolacin O2 against barnacles. J. Nat. Prod. 2004; 67: 1287-1290.
87. Colgrave ML, Kotze AC, Huang YH, O'Grady J, Simonsen SM, Craik DJ. Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry 2008; 47: 5581-5589.
88. Colgrave ML, Kotze AC, Ireland DC, Wang CK, Craik DJ. The anthelmintic activity of the cyclotides: natural variants with enhanced activity. Chembiochem 2008; 9: 1939-1945.
89. Colgrave ML, Kotze AC, Kopp S, McCarthy JS, Coleman GT, Craik DJ. Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms. Acta Trop. 2009; 109: 163-166.
90. Plan MRR, Saska I, Cagauan AG, Craik DJ. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (Golden Apple Snail). J. Agric. Food Chem. 2008; 56: 5237-5241.
91. Smith AB, Daly NL, Craik DJ. Cyclotides: a patent review. Expert Opin. Ther. Pat. 2011; 21: 1657-1672.
92. Barbeta BL, Marshall AT, Gillon AD, Craik DJ, Anderson MA. Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 1221-1225.
93. Colgrave ML, Huang YH, Craik DJ, Kotze AC. Cyclotide interactions with the nematode external surface. Antimicrob. Agents Chemother. 2010; 54: 2160-2166.
94. Burman R, Stromstedt AA, Malmsten M, Goransson U. Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption. BBA-Biomembranes 2011; 1808: 2665-2673.
95. Kamimori H, Hall K, Craik DJ, Aguilar MI. Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance. Anal. Biochem. 2005; 337: 149-153.
96. Henriques ST, Huang YH, Castanho MARB, Bagatolli LA, Sonza S, Tachedjian G, et al. Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions. J. Biol. Chem. 2012; 287: 33629-33643.
97. Henriques ST, Huang YH, Rosengren KJ, Franquelim HG, Carvalho FA, Johnson A, et al. Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organisation on hemolytic and anti-HIV activities. J. Biol. Chem. 2011; 286: 24231-24241.
98. Huang YH, Colgrave ML, Daly NL, Keleshian A, Martinac B, Craik DJ. The biological activity of the prototypic cyclotide kalata b1 is modulated by the formation of multimeric pores. J. Biol. Chem. 2009; 284: 20699-20707.
99. Wang CK, Wacklin HP, Craik DJ. Cyclotides insert into lipid bilayers to form membrane pores and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions. J. Biol. Chem. 2012; 287: 43884-43898.
100. Conlan BF, Gillon AD, Barbeta BL, Anderson MA. Subcellular Targeting and Biosynthesis of Cyclotides in Plant Cells. Am. J. Bot. 2011; 98: 2018-2026.
101. Dutton JL, Renda RF, Waine C, Clark RJ, Daly NL, Jennings CV, et al. Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteins. J. Biol. Chem. 2004; 279: 46858-46867.
102. Mulvenna JP, Sando L, Craik DJ. Processing of a 22kDa precursor protein to produce the circular protein tricyclon A. Structure 2005; 13: 691-701.
103. Sando L, Bharathi R, Craik DJ. Novel gene sequences of cyclotides. Biopolymers: Pept. Sci. 2005; 80: 514.
104. Trabi M, Mylne JS, Sando L, Craik DJ. Circular proteins from Melicytus (Violaceae) refine the conserved protein and gene architecture of cyclotides. Org. Biomol. Chem. 2009; 7: 2378-2388.
105. Mulvenna JP, Mylne JS, Bharathi R, Burton RA, Shirley NJ, Fincher GB, et al. Discovery of cyclotide-like protein sequences in graminaceous crop plants: ancestral precursors of circular proteins? Plant Cell 2006; 18: 2134-2144.
106. Burman R, Gruber CW, Rizzardi K, Herrmann A, Craik DJ, Gupta MP, et al. Cyclotide proteins and precursors from the genus Gloeospermum: Filling a blank spot in the cyclotide map of Violaceae. Phytochemistry 2010; 71: 13-20.
107. Zhang J, Hu M, Li JT, Guan JP, Yang B, Shu WS, et al. A transcriptional profile of metallophyte Viola baoshanensis involved in general and species-specific cadmium-defense mechanisms. J. Plant Physiol. 2009; 166: 862-870.
108. Nguyen GK, Lian YL, Pang EWH, Phuong QTN, Tran TD, Tam JP. Discovery of linear cyclotides in monocot plant panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants. J. Biol. Chem. 2013; 288: 3370-3380.
109. Saska I, Gillon AD, Hatsugai N, Dietzgen RG, Hara-Nishimura I, Anderson MA, et al. An asparaginyl endopeptidase mediates in vivo protein backbone cyclisation. J. Biol. Chem. 2007; 282: 29721-29728.
110. Gillon AD, Saska I, Jennings CV, Guarino RF, Craik DJ, Anderson MA. Biosynthesis of circular proteins in plants. Plant J. 2008; 53: 505-515.
111. Conlan BF, Gillon AD, Craik DJ, Anderson MA. Circular proteins and mechanisms of cyclization. Biopolymers: Pept. Sci. 2010; 94: 573-583.
112. Gustafson KR, Walton LK, Sowder RCI, Johnson DG, Pannell LK, Cardellina JHI, et al. New circulin macrocyclic polypeptides from Chassalia parvifolia. J. Nat. Prod. 2000; 63: 176-178.
113. Mylne JS, Colgrave ML, Daly NL, Chanson AH, Elliott AG, McCallum EJ, et al. Albumins and their processing machinery are hijacked for cyclic peptides in sunflower. Nat. Chem. Biol. 2011; 7: 257-259.
114. Tam JP, Lu YA, Yang JL, Chiu KW. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 8913-8918.
115. Pränting M, Loov C, Burman R, Goransson U, Andersson DI. The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J. Antimicrob. Chemother. 2010; 65: 1964-1971.
116. Nguyen GKT, Zhang S, Wang W, Wong CTT, Ngan TKN, Tam JP. Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry. J. Biol. Chem. 2011; 286: 44833-44844.
117. Yeshak MY, Burman R, Asres K, Goransson U. Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands. J. Nat. Prod. 2011; 74: 727-731.
118. Broussalis AM, Clemente S, Ferraro GE. Hybanthus parviflorus (Violaceae): insecticidal activity of a South American plant. Crop Prot. 2010; 29: 953-956.
119. Pinto MFS, Fensterseifer ICM, Migliolo L, Sousa DA, de Capdville G, Arboleda-Valencia JW, et al. Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane. J. Biol. Chem. 2012; 287: 134-147.
120. Hallock YF, Sowder RCI, Pannell LK, Hughes CB, Johnson DG, Gulakowski R, et al. Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa. J. Org. Chem. 2000; 65: 124-128.
121. Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ. Cyclotides as natural anti-HIV agents. Biopolymers: Pept. Sci. 2008; 90: 51-60.
122. Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ. Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J. Nat. Prod. 2008; 71: 47-52.
123. Daly NL, Clark RJ, Plan MR, Craik DJ. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem. J. 2006; 393: 619-626.
124. Daly NL, Gustafson KR, Craik DJ. The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1. FEBS Lett. 2004; 574: 69-72.
125. Bokesch HR, Pannell LK, Cochran PK, Sowder RC, 2nd, McKee TC, Boyd MR. A novel anti-HIV macrocyclic peptide from Palicourea condensata. J. Nat. Prod. 2001; 64: 249-250.
126. Chen B, Colgrave ML, Daly NL, Rosengren KJ, Gustafson KR, Craik DJ. Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide. J. Biol. Chem. 2005; 280: 22395-22405.
127. Gerlach SL, Burman R, Bohlin L, Mondal D, Goransson U. Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa. J. Nat. Prod. 2010; 73: 1207-1213.
128. Gerlach SL, Rathinakumar R, Chakravarty G, Goransson U, Wimley WC, Darwin SP, et al. Anticancer and chemosensitizing abilities of cycloviolacin O2 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers: Pept. Sci. 2010; 94: 617-625.
129. Lindholm P, Göransson U, Johansson S, Claeson P, Gulbo J, Larsson R, et al. Cyclotides: a novel type of cytotoxic agents. Mol. Cancer Ther. 2002; 1: 365-369.
130. Herrmann A, Burman R, Mylne JS, Karlsson G, Gullbo J, Craik DJ, et al. The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry 2008; 69: 939-952.
131. Wenjun H, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N. Isolation and characterization of cytotoxic cyclotides from Viola philippica. Peptides 2011; 32: 1719-1723.
132. He W, Chan LY, Zeng G, Daly NL, Craik DJ, Tan N. Isolation and characterization of cytotoxic cyclotides from Viola philippica. Peptides 2011; 32: 1719-1723.
133. Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, et al. Isolation and characterization of cytotoxic cyclotides from Viola tricolor. Peptides 2010; 31: 1434-1440.
134. Svangard E, Göransson U, Hocaoglu Z, Gullbo J, Larsson R, Claeson P, et al. Cytotoxic cyclotides from Viola tricolor. J. Nat. Prod. 2004; 67: 144-147.
135. Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, et al. Isolation and characterization of bioactive cyclotides from Viola labridorica. Helv. Chim. Acta 2010; 93: 2287-2295.
136. Getz JA, Rice JJ, Daugherty PS. Protease-resistant peptide ligands from a knottin scaffold library. ACS Chem. Biol. 2011; 6: 837-844.
137. Chan LY, Gunasekera S, Henriques ST, Worth NF, Le SJ, Clark RJ, et al. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood 2011; 118: 6709-6717.
138. Kimura RH, Teed R, Hackel BJ, Pysz MA, Chuang CZ, Sathirachinda A, et al. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clin. Cancer Res. 2012; 18: 839-849.
139. Poth AG, Chan LY, Craik DJ. Cyclotides as grafting frameworks for protein engineering and drug design applications. Biopolymers: Pept. Sci. 2013; (in press).
140. Daly NL, Craik DJ. Folding motifs of cystine-rich peptides. In Oxidative Folding of Proteins and Peptides, Buchner J, Moroder L (eds). RSC Publishing: London, 2009; 318-244.